Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Cytosorbents Corporation on June 7, 2016. The filing details the outcomes of shareholder votes regarding board elections and auditor ratification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events.
Material Changes
No material financial changes are reported in this document. The primary event is the successful election of the board of directors and the ratification of the independent auditor.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, management commentary on operations, or discussion of risks and contingencies. It strictly documents the voting results of the Annual Meeting.
Important Facts for Investors
- Meeting Date: June 7, 2016.
- Shareholder Participation: 20,353,135 shares were represented at the meeting out of 25,410,101 outstanding shares, establishing a quorum.
- Board Election: All five nominees (Phillip P. Chan, Al W. Kraus, Edward R. Jones, Michael G. Bator, and Alan D. Sobel) were elected to serve until the 2017 Annual Meeting.
- Auditor Ratification: Stockholders approved the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the year ending December 31, 2016.
- Voting Results: Proposal 2 received 20,271,312 votes "For," 54,304 "Against," and 27,514 "Abstain."